GEMWEL 200MG INJ
Prescription Required
Sale price
₹ 300.00
Regular price
MRP: ₹ 1,354.69
78% OFF
Inclusive of all taxes.
Couldn't load pickup availability
GEMWEL 200MG INJ
Regular price
₹ 300.00
Regular price
₹ 1,354.69
Sale price
₹ 300.00
(-78%)
Unit price
per
GEMWEL 200MG INJ
Sale price
₹ 300.00
Regular price
MRP: ₹ 1,354.69
78% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Gemwel 200mg Injection contains gemcitabine, an antimetabolite chemotherapy medicine that interferes with DNA synthesis in rapidly dividing cancer cells.
Uses
Gemwel 200mg Injection is used for the treatment of several solid tumours.
- Pancreatic cancer
- Breast cancer
- Ovarian cancer
- Bladder cancer
- Non-small cell lung cancer
Storage
- Store below 25°C in the original packaging.
- Use the reconstituted solution according to hospital guidelines.
Safety Information
- Regular monitoring of blood counts, liver function and kidney function is recommended during therapy.
Possible Side Effects
Possible side effects may include:
- Anaemia
- Neutropenia
- Thrombocytopenia
- Nausea
- Vomiting
- Fatigue
- Fever
- Rash
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Gemwel is a prescription anticancer medicine.
It should only be administered under the supervision of a qualified oncologist.